ERAP1+/− mice showed mildly increased susceptibility to DSS-induced colitis, evidenced by greater weight loss and altered expression of immune cell markers, including those of neutrophils, DCs, T cells, and NK cells even after sulfasalazine treatment. The gene discussed is ERAP1; the disease is colitis.